Dow Up0.64% Nasdaq Up0.68%

Agile Therapeutics, Inc. (AGRX)

8.75 Up 0.55(6.71%) 4:00PM EDT
ProfileGet Profile for:
Agile Therapeutics, Inc.
101 Poor Farm Road
Princeton, NJ 08540
United States - Map
Phone: 609-683-1880

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:11

Business Summary 

Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a levonorgestrel-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Agile Therapeutics, Inc.

Key Executives 
Mr. Alfred F. Altomari , 55
Chief Exec. Officer, Pres and Director
Mr. Scott M. Coiante , 47
Chief Financial Officer, Principal Accounting Officer and VP
Mr. Robert G. Conway M.E.,
Chief Devel. Officer and VP of Operations
Dr. Agis Kydonieus Ph.D.,
Chief Scientific Officer
Ms. Katie MacFarlane Pharm.D., 48
Chief Commercial Officer and Consultant Commercial
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders